Parliament MB - Search Results

1

Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV.

Michalski JM, Winter K, Purdy JA, Perez CA, Ryu JK, Parliament MB, Valicenti RK, Roach M 3rd, Sandler HM, Markoe AM, Cox JD. Michalski JM, et al. Among authors: parliament mb. Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):735-42. doi: 10.1016/S0360-3016(03)01578-5. Int J Radiat Oncol Biol Phys. 2004. PMID: 14967428 Clinical Trial.

2

A prospective study of ultrasound localization for renal shielding.

Parliament MB, Danjoux CJ, Lewandowski BJ, Eapen LJ, Esche BA, McDermot RS, Nair BD. Parliament MB, et al. Int J Radiat Oncol Biol Phys. 1991 Oct;21(5):1363-6. doi: 10.1016/0360-3016(91)90298-i. Int J Radiat Oncol Biol Phys. 1991. PMID: 1938536

3

Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four radiation therapy oncology group (RTOG) studies in inoperable nonsmall-cell lung cancer (NSCLC).

Komaki R, Scott CB, Byhardt R, Emami B, Asbell SO, Russell AH, Roach M, Parliament MB, Gaspar LE. Komaki R, et al. Among authors: parliament mb. Int J Radiat Oncol Biol Phys. 1998 Sep 1;42(2):263-7. doi: 10.1016/s0360-3016(98)00213-2. Int J Radiat Oncol Biol Phys. 1998. PMID: 9788403

4

Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trials.

Cox JD, Scott CB, Byhardt RW, Emami B, Russell AH, Fu KK, Parliament MB, Komaki R, Gaspar LE. Cox JD, et al. Among authors: parliament mb. Int J Radiat Oncol Biol Phys. 1999 Feb 1;43(3):505-9. doi: 10.1016/s0360-3016(98)00429-5. Int J Radiat Oncol Biol Phys. 1999. PMID: 10078629

5

Muscle-invasive transitional cell carcinoma of the urinary bladder: a population-based study of patterns of care and prognostic factors.

Scrimger RA, Murtha AD, Parliament MB, Venner PM, Hanson J, Houle G, Chetner M. Scrimger RA, et al. Among authors: parliament mb. Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):23-30. doi: 10.1016/s0360-3016(01)01591-7. Int J Radiat Oncol Biol Phys. 2001. PMID: 11516847

6

Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on Radiation Therapy Oncology Group 9406.

Michalski JM, Winter K, Purdy JA, Wilder R, Perez CA, Roach M, Parliament M, Pollack A, Markoe A, Harms WB, Sandler H, Cox JD. Michalski JM, et al. Semin Radiat Oncol. 2002 Jan;12(1 Suppl 1):75-80. doi: 10.1053/srao.2002.31378. Semin Radiat Oncol. 2002. PMID: 11917289 Clinical Trial.

7

Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II.

Michalski JM, Winter K, Purdy JA, Wilder RB, Perez CA, Roach M, Parliament MB, Pollack A, Markoe AM, Harms W, Sandler HM, Cox JD. Michalski JM, et al. Among authors: parliament mb. Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):192-8. doi: 10.1016/s0360-3016(03)00072-5. Int J Radiat Oncol Biol Phys. 2003. PMID: 12694838

8

Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.

Parliament MB, Scrimger RA, Anderson SG, Kurien EC, Thompson HK, Field GC, Hanson J. Parliament MB, et al. Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):663-73. doi: 10.1016/S0360-3016(03)01571-2. Int J Radiat Oncol Biol Phys. 2004. PMID: 14967418 Clinical Trial.

9

Phenomenologic model describing flow reduction for parotid gland irradiation with intensity-modulated radiotherapy: evidence of significant recovery effect.

Scrimger RA, Stavrev P, Parliament MB, Field C, Thompson H, Stavreva N, Fallone BG. Scrimger RA, et al. Among authors: parliament mb. Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):178-85. doi: 10.1016/j.ijrobp.2004.02.041. Int J Radiat Oncol Biol Phys. 2004. PMID: 15337554

10

Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: a report from the Radiation Therapy Oncology Group.

Chakravarti A, Winter K, Wu CL, Kaufman D, Hammond E, Parliament M, Tester W, Hagan M, Grignon D, Heney N, Pollack A, Sandler H, Shipley W. Chakravarti A, et al. Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):309-17. doi: 10.1016/j.ijrobp.2004.09.047. Int J Radiat Oncol Biol Phys. 2005. PMID: 15890569

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters